On May 14, Dr. Liu Muyun, a special researcher at the China (Shenzhen) Institute for Comprehensive Development and director of the National and Local Joint Laboratory of Engineering for Personalized Cell Therapy Technology, met with enterprise representatives from the life and health industries of other BRICS member countries under the theme of “BRICS Collaboration” and held an online remote meeting.Liu Muyun shared the Chinese government’s anti-epidemic measures and the impact of the epidemic on individuals and enterprises under the theme of “New Normal after the Epidemic”, and elaborated on the “new normal” after the epidemic, which includes strict control over the entry and exit of personnel and materials, and strengthening the resilience of global supply chains, the rise of contactless business models, technological innovations in life and health infrastructure, etc.At present, the COVID-19 epidemic is sweeping the world and it is of great importance to discuss how to implement the United Nations Sustainable Development Goals related to health. This meeting aims to promote coordinated and efficient cooperation among BRICS countries to jointly combat the global COVID-19 epidemic. Representatives of BRICS companies participating in the meeting jointly discussed anti-epidemic mechanisms for sharing information and knowledge, special mechanisms for ensuring medical supplies and mechanisms for allocating funds. Other guests present at the meeting included: Shroff, CEO of UPL Company of India, Dora, CEO of the BRICS-PED BRICS Chamber of Commerce, Sergey, General Manager of Russian Agricultural Ecology and Biotechnology Co., Ltd., Russian Digital Business Council Nesterova, head of the economic working group, and Nikolaou, senior executive of the strategic business group of Aspen Pharmaceuticals in South Africa.http://www.cdi.com.cn/Article/Detail?Id=17183
